article thumbnail

Expanding Your Assay Specificity: Cisbio Joins PerkinElmer

PerkinElmer

Over the last 20 years, Cisbio has become a leading Life Sciences company which develops, manufactures, and markets high quality kits and reagents for the drug discovery and life science markets used by pharmaceutical, biotechnology, academia and contract research organizations across the globe.

article thumbnail

Applying ICH Q14 in Pharmaceuticals Part 1: The Application of Analytical Target Profile in Analytical Method Development

The Premier Consulting Blog

The ICH Q14 guideline describes principles to support change management of analytical procedures based on risk management, comprehensive understanding of the analytical procedure, and adherence to predefined criteria for performance characteristics. Pharmaceutical Development Q8(R2). ICH Harmonised Guideline. ICH Harmonised Guideline.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Altasciences Completes Expansion of New State-Of-The-Art Laboratory in Columbia, Missouri

Alta Sciences

About Altasciences Altasciences is an integrated drug development solution company offering pharmaceutical and biotechnology companies a proven, flexible approach to preclinical and clinical pharmacology studies , including formulation, manufacturing, and analytical services.

article thumbnail

ASLAN Pharmaceuticals to Develop ASLAN003 as Next Generation DHODH Inhibitor in Autoimmune Conditions

The Pharma Data

ASLAN003 is a highly selective and potent inhibitor of human DHODH (IC 50 = 35 nM) and has been shown to be more than 30 times more potent at inhibiting the DHODH enzyme in cell free and cell-based assays than the first generation inhibitor teriflunomide. SINGAPORE, Oct. M edia and IR contacts.

article thumbnail

Accelerating Drug Discovery Through Repurposing

DrugBank

The pharmaceutical industry grapples with the persistent challenge of high attrition rates and escalating costs inherent in drug development. Key techniques include high-throughput screening (HTS), cell-based assays, and animal models.

article thumbnail

An industry leader’s perspective on the complexity of scientific data

Drug Target Review

Data-driven discovery As with many early-stage biotech companies, Five Alarm Bio is highly data-driven, producing vast amounts of experimental data through cell-based assays and phenotypic screening.

article thumbnail

AI At The Frontier: Empowering Early Career Professionals In Drug Discovery

Elrig

His current research concerns the use of quantum chemistry and machine learning to understand chemical reactivity, with the aim of providing insights into the most widely used reaction classes in pharmaceutical synthesis and enabling chemists to design and optimise new synthetic routes to molecules.